Inhibitory effects of zinc hyaluronate on synoviocyte growth and matrix metalloproteinase-9 activity
Seiji Saito, Keisei Maekawa, Shigeru KotakeInstitute of Rheumatology, Tokyo Women’s Medical University, Tokyo, JapanAbstract: Sodium hyaluronate (Na-HA) is a therapeutic agent used for treating knee arthritis. However, it has been unsuccessfully used in the treatment of knee effusions....
Guardado en:
Autores principales: | Seiji Saito, Keisei Maekawa, Shigeru Kotake |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d9e3084f9bd74caba0437ca97f4471e9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Implications of compromised zinc status on bone loss associated with chronic inflammation in C57BL/6 mice
por: Chongwatpol P, et al.
Publicado: (2015) -
Syndecan-1 Shedding by Matrix Metalloproteinase-9 Signaling Regulates Alveolar Epithelial Tight Junction in Lipopolysaccharide-Induced Early Acute Lung Injury
por: Zhang D, et al.
Publicado: (2021) -
Epigallocatechin-3-gallate suppresses proinflammatory cytokines and chemokines induced by Toll-like receptor 9 agonists in prostate cancer cells
por: Mukherjee S, et al.
Publicado: (2014) -
Metalloproteinases in Inflammatory Bowel Diseases
por: Marônek M, et al.
Publicado: (2021) -
A Role for Mucolytics and Expectorants in Aiding Inhaled Therapies in Asthma? [Response To Letter]
por: Kurukulaaratchy RJ, et al.
Publicado: (2021)